Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 12Breast Neoplasms 11Lung Neoplasms 6Prostatic Neoplasms 5Colorectal Neoplasms 5Uterine Cervical Neoplasms 4Thyroid Neoplasms 2Smoking Cessation 2Motor Activity 2Lymphoma 2Hematologic Neoplasms 2Communication 2Uveal Melanoma 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Tobacco Use Disorder 1Tobacco Use Cessation 1Thyroid Diseases 1Substance-Related Disorders 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Sexual Dysfunction, Physiological 1Sedentary Behavior 1Rectal Neoplasms 1Patient Preference 1Patient Acceptance of Health Care 1Papillomavirus Infections 1Papillary Thyroid Microcarcinoma 1Neoplasms, Plasma Cell 1

Interventions

palbociclib 1exemestane 1delta 24-sterol reductase 1Vinorelbine 1Therapeutics 1Tamoxifen 1Standard of Care 1Risk Assessment 1Paclitaxel 1Letrozole 1Influenza Vaccines 1Fulvestrant 1Focus Groups 1Epirubicin 1Drug Therapy 1Counseling 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Patient Acceptance of Health Care × Focus Groups × Clear all
NCT06559462 2025-11-25

DPYD Nudges

Abramson Cancer Center at Penn Medicine

Phase NA Completed
50 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Patient Acceptance of Health Care

Data powered by HemOnc (CC BY 4.0) Colophon âš¡